Explore the full insider trade history of Kyverna Therapeutics, Inc., a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €477.2m. The latest transaction was reported on 29 May 2026 (Attribution). Among the most active insiders: Cohen Fred E. Every trade is accessible without an account.
14
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
27Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.